NO950592L - Fremgangsmåte for isolering av insulin med korrekt koblede cysteinbroer - Google Patents

Fremgangsmåte for isolering av insulin med korrekt koblede cysteinbroer

Info

Publication number
NO950592L
NO950592L NO950592A NO950592A NO950592L NO 950592 L NO950592 L NO 950592L NO 950592 A NO950592 A NO 950592A NO 950592 A NO950592 A NO 950592A NO 950592 L NO950592 L NO 950592L
Authority
NO
Norway
Prior art keywords
insulin
arg
peptide
lys
protein
Prior art date
Application number
NO950592A
Other languages
English (en)
Other versions
NO950592D0 (no
NO318424B1 (no
Inventor
Rainer Obermeier
Martin Gerl
Jurgen Ludwig
Walter Sabel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO950592D0 publication Critical patent/NO950592D0/no
Publication of NO950592L publication Critical patent/NO950592L/no
Publication of NO318424B1 publication Critical patent/NO318424B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19950592A 1994-02-18 1995-02-17 Fremgangsmate for isolering av insulin med korrekt koblede cysteinbroer NO318424B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4405179A DE4405179A1 (de) 1994-02-18 1994-02-18 Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken

Publications (3)

Publication Number Publication Date
NO950592D0 NO950592D0 (no) 1995-02-17
NO950592L true NO950592L (no) 1995-08-21
NO318424B1 NO318424B1 (no) 2005-04-18

Family

ID=6510552

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19950592A NO318424B1 (no) 1994-02-18 1995-02-17 Fremgangsmate for isolering av insulin med korrekt koblede cysteinbroer

Country Status (15)

Country Link
US (1) US5663291A (no)
EP (1) EP0668292B1 (no)
JP (1) JP3863579B2 (no)
KR (1) KR100371824B1 (no)
AT (1) ATE166069T1 (no)
AU (1) AU699817B2 (no)
CA (1) CA2142780C (no)
DE (2) DE4405179A1 (no)
DK (1) DK0668292T3 (no)
ES (1) ES2119241T3 (no)
FI (1) FI115916B (no)
HK (1) HK1010457A1 (no)
IL (1) IL112680A0 (no)
NO (1) NO318424B1 (no)
SG (1) SG46683A1 (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59711533D1 (de) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulinderivate mit erhöhter Zinkbindung
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19825447A1 (de) * 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
FI107115B (fi) * 1998-09-30 2001-06-15 Valio Oy Menetelmä naudan insuliinin poistamiseksi
EP0994188B1 (de) 1998-10-09 2004-01-07 Scil proteins GmbH Verfahren zur Gewinnung von aktivem Beta-NGF
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US6746853B1 (en) 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
WO2002100887A2 (en) * 2001-06-08 2002-12-19 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
DE602004025192D1 (de) * 2003-12-05 2010-03-11 Roche Diagnostics Gmbh Rekombinante Carboxypeptidase B und ihre Aufreinigung
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
DE102006031955A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
MY161892A (en) * 2008-02-19 2017-05-15 Biocon Ltd A method of obtaining a purified, biologically active heterologous protein
EP2274318B1 (en) * 2008-04-30 2014-08-13 Wockhardt Limited Processes for refolding of insulin
PL219335B1 (pl) * 2008-07-04 2015-04-30 Inst Biotechnologii I Antybiotyków Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, jej zastosowanie oraz zawierająca ją kompozycja farmaceutyczna
EP3228320B1 (de) 2008-10-17 2019-12-18 Sanofi-Aventis Deutschland GmbH Kombination von einem insulin und einem glp-1-agonisten
UA91281C2 (ru) * 2008-11-26 2010-07-12 Общество С Ограниченной Ответственностью «Мако» Способ получения рекомбинантного инсулина человека
UY33025A (es) 2009-11-13 2011-06-30 Sanofi Aventis Deustschland Gmbh Composicion farmaceutica que comprende un agonista de glp-1 metionina
AR080669A1 (es) 2009-11-13 2012-05-02 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1, una insulina y metionina
MX339614B (es) 2010-08-30 2016-06-02 Sanofi - Aventis Deutschland GmbH Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
EP2694573B1 (en) 2011-04-01 2020-05-27 3M Innovative Properties Company Films comprising triazine-based ultraviolet absorbers
DK2739646T3 (en) * 2011-05-10 2018-02-26 Stefan Hermann COMPREHENSIVE BUFFER SYSTEM FOR RENATURING HUMAN PROINSULIN OR PROINSULIN DERIVATIVES
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP2931301B2 (en) 2012-12-17 2021-09-15 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
EP3116531B1 (en) 2014-03-14 2021-10-20 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU76881A (en) * 1980-03-27 1984-04-30 Lilly Co Eli Process for obtaining insulin precursors
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
DE4012818A1 (de) * 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE58906966D1 (de) * 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
DE4028120C2 (de) * 1990-09-05 1996-09-19 Hoechst Ag Verfahren zur Reinigung von Insulin und/oder Insulinderivaten
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
EP0599303A3 (en) * 1992-11-27 1998-07-29 Takeda Chemical Industries, Ltd. Peptide conjugate
DK0600372T3 (da) * 1992-12-02 1997-08-11 Hoechst Ag Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.
US5523293A (en) * 1994-05-25 1996-06-04 Iowa State University Research Foundation, Inc. Soy protein-based thermoplastic composition for preparing molded articles

Also Published As

Publication number Publication date
ES2119241T3 (es) 1998-10-01
HK1010457A1 (en) 1999-06-17
US5663291A (en) 1997-09-02
AU699817B2 (en) 1998-12-17
EP0668292B1 (de) 1998-05-13
AU1228895A (en) 1995-08-31
JPH07265092A (ja) 1995-10-17
JP3863579B2 (ja) 2006-12-27
CA2142780A1 (en) 1995-08-19
FI950699A (fi) 1995-08-19
DK0668292T3 (da) 1998-11-23
SG46683A1 (en) 1998-02-20
CA2142780C (en) 2008-10-14
DE4405179A1 (de) 1995-08-24
KR100371824B1 (ko) 2003-04-10
NO950592D0 (no) 1995-02-17
EP0668292A3 (de) 1996-02-07
FI950699A0 (fi) 1995-02-16
KR950032282A (ko) 1995-12-20
FI115916B (fi) 2005-08-15
NO318424B1 (no) 2005-04-18
IL112680A0 (en) 1995-05-26
ATE166069T1 (de) 1998-05-15
DE59502138D1 (de) 1998-06-18
EP0668292A2 (de) 1995-08-23

Similar Documents

Publication Publication Date Title
NO950592D0 (no) Fremgangsmåte for isolering av insulin med korrekt koblede cysteinbroer
FI108727B (fi) Menetelmä oikein sitoutuneet kystiinisillat omaavan proinsuliinin saamiseksi
KR19990023651A (ko) 정확하게 결합된 시스틴 브릿지를 갖는 인슐린 전구체를 수득하는 방법
CA1318869C (en) Method of removing n-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby
DE69929805D1 (de) Modifiziertes e.coli enterotoxin ii signalpeptid sowie ein mikroorganismus der ein fusionsprotein sowie ein heterologes protein exprimiert
ATE41162T1 (de) Verfahren zur herstellung von insulin-derivaten.
PT78979A (de) Herstellung von polypeptiden mit einem saeureamid-carboxyterminus
ATE381619T1 (de) Verfahren zur herstellung von rekombinantem insulin durch fusionsproteine
ATE290088T1 (de) Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
NZ196609A (en) Preparation of proinsulin-like insulin precursors
Yamasaki et al. Studies on the common active site of growth hormone. Revision of the amino acid sequence of an active fragment of bovine growth hormone.
Wakabayashi et al. Amino Acid Sequences of Two Ferredoxins from Phytolacca esculenta Gene Duplication and Speciation
DE69428401D1 (de) Verfahren zur Herstellung von alpha-Aminosäureamiden zur Verwendung in der Peptidsynthese
DE69526462D1 (de) Verfahren zur Herstellung von Peptiden aus N-Carboxyanhydridaminosäuren
ATE101616T1 (de) Verfahren zur herstellung von dipeptiden.
Canova-Davis et al. Specific activation of the arginine carboxyl group of the B-chain of bovine des-octapeptide-(B23–30)-insulin
MXPA98006666A (en) Improved procedure for the obtaining of insulin precursors with cistina bridges correctly uni

Legal Events

Date Code Title Description
MK1K Patent expired